Developing recombinant antibodies by phage display technology to neutralize viral infectious diseases
The use of recombinant antibodies developed through phage display technology offers a promising approach for combating viral infectious diseases. By specifically targeting antigens on viral surfaces, these antibodies have the potential to reduce the severity of infections or even prevent them altoge...
Main Authors: | Mujahed I. Mustafa, Ahmed Mohammed |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | SLAS Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2472555224000017 |
Similar Items
-
Generation of hapten-specific recombinant antibodies: antibody phage display technology: a review
by: J. Brichta, et al.
Published: (2005-06-01) -
Evolution of phage display libraries for therapeutic antibody discovery
by: Yang Zhang
Published: (2023-12-01) -
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
by: Kristian Daniel Ralph Roth, et al.
Published: (2021-07-01) -
Oligopeptide M13 Phage Display in Pathogen Research
by: Michael Hust, et al.
Published: (2013-10-01) -
Phage Display Technology as a Powerful Platform for Antibody Drug Discovery
by: Kazuya Nagano, et al.
Published: (2021-01-01)